Pages in category "Medication templates"
The following 109 pages are in this category, out of 109 total. This list may not reflect recent changes.
A
- Template:Affinities and estrogenic potencies of estrogen esters and ethers at the estrogen receptors
- Template:Affinities of estrogen receptor ligands for the ERα and ERβ
- Template:Affinities of selected androgen receptor ligands
- Template:Amphetamine base in marketed amphetamine medications
- Template:Androgen replacement therapy formulations and dosages used in men
- Template:Androgen replacement therapy formulations and dosages used in women
- Template:Androgen/anabolic steroid dosages for breast cancer
- Template:Available forms of estradiol
- Template:Available forms of progesterone
- Template:Available forms of testosterone
C
- Template:Chemical structures of equine estrogens
- Template:Chemical structures of major endogenous estrogens
- Template:Chemical structures of major endogenous estrogens medication version
- Template:Classification of estrogens and antiestrogens by receptor–estrogen complex retention
- Template:Comparison of early clinical experience with antiestrogens for advanced breast cancer
- Template:Composition of conjugated estrogens and properties of constituents
E
H
- Template:Hormone levels with estradiol and estradiol esters by intramuscular injection
- Template:Hormone levels with estradiol benzoate/estradiol dienanthate/testosterone enanthate benzilic acid hydrazone by intramuscular injection
- Template:Hormone levels with gonadotropin-releasing hormone agonists and antagonists
- Template:Hormone levels with nandrolone esters by intramuscular injection
- Template:Hormone levels with oral estradiol
- Template:Hormone levels with sublingual estradiol
- Template:Hormone levels with transdermal estradiol patches
M
P
- Template:Parenteral durations of androgens/anabolic steroids
- Template:Parenteral potencies and durations of nonsteroidal estrogens
- Template:Parenteral potencies and durations of progestogens
- Template:Pharmacodynamics of aromatase inhibitors
- Template:Pharmacodynamics of progestogens
- Template:Pharmacokinetic parameters of progesterone by different routes
- Template:Pharmacokinetics of 100 mg per day spironolactone and its metabolites
- Template:Pharmacokinetics of long-acting injectable antipsychotics
- Template:Pharmacokinetics of progestogens
- Template:Pharmacokinetics of testosterone esters
- Template:Pharmacokinetics of three estradiol esters by intramuscular injection
- Template:Pharmacological properties of major anabolic steroids
- Template:Pharmacology of estrone
- Template:Plasma estrogen levels after a single dose of conjugated estrogens by different routes
- Template:Plasma estrogen levels after a single dose of estradiol by different routes
- Template:Plasma levels and binding potential of flutamide and bicalutamide during first week
- Template:Potencies and durations of natural estrogens by intramuscular injection
- Template:Progesterone metabolism
- Template:Protein binding and metabolic clearance rates of estrogens
- Template:Published case reports of bicalutamide-associated liver injury
- Template:Published case reports of bicalutamide-associated lung toxicity
- Template:Published case reports of cyproterone acetate-associated liver toxicity
- Template:Published case reports of cyproterone acetate-associated meningioma
- Template:Published case reports of cyproterone acetate-associated prolactinoma
R
- Template:Relative affinities of anabolic steroids and related steroids
- Template:Relative affinities of estrogens for steroid hormone receptors and blood proteins
- Template:Relative affinities of first-generation nonsteroidal antiandrogens for the androgen receptor
- Template:Relative affinities of hydroxyprogesterone and related steroids
- Template:Relative affinities of levonorgestrel and metabolites
- Template:Relative affinities of nandrolone and related steroids
- Template:Relative affinities of nandrolone and related steroids at the androgen receptor
- Template:Relative affinities of norethisterone, metabolites, and prodrugs
- Template:Relative affinities of noretynodrel, tibolone, and metabolites
- Template:Relative affinities of normethandrone and metabolites
- Template:Relative androgenic to anabolic activity in animals
- Template:Relative interconversion rates of estradiol, estrone, and estrone sulfate in tissues throughout the body
- Template:Relative oral potencies of estrogens
- Template:Relative potencies of selected antiandrogens
- Template:Results of the Women's Health Initiative menopausal hormone therapy randomized controlled trials
- Template:Risk of breast cancer with menopausal hormone therapy by duration in large observational studies
- Template:Risk of breast cancer with menopausal hormone therapy in large observational studies
- Template:Risk of venous thromboembolism with hormone therapy and birth control pills (QResearch/CPRD)
S
- Template:Selected biological properties of endogenous estrogens in rats
- Template:Side effects of bremelanotide in phase 3 clinical trials
- Template:Side effects of combined androgen blockade with flutamide
- Template:Side effects of combined androgen blockade with nilutamide and a GnRH agonist
- Template:Side effects of combined androgen blockade with nilutamide and surgical castration
- Template:Side effects of combined androgen blockade with nonsteroidal antiandrogens
- Template:Side effects of cyproterone acetate in the SExual-HOrmonal Surveillance STudy (SEHOST)
- Template:Side effects of estradiol undecylate versus cyproterone acetate in men
- Template:Side effects of estramustine phosphate (EMC)
- Template:Side effects of estramustine phosphate (FDA)
- Template:Side effects of estrogen plus high- versus low-dose cyproterone acetate in women
- Template:Side effects of high-dose cyproterone acetate
- Template:Side effects of lower versus higher dose oral estradiol
- Template:Side effects of spironolactone in women in clinical studies for acne
- Template:Spirolactone structures
- Template:Spironolactone at steroid hormone receptors
- Template:Structural aspects of androgens and anabolic steroids
- Template:Structural aspects of progestogens used in clinical and veterinary medicine
- Template:Structural properties of major anabolic steroid esters
- Template:Structural properties of major testosterone esters
- Template:Structural properties of selected estradiol esters
T
- Template:Tamoxifen dosage and incidence of breast symptoms with bicalutamide in men
- Template:Target ranges for hormone levels in hormone therapy for transgender women
- Template:Testosterone levels in males and females
- Template:Testosterone levels with cyproterone acetate
- Template:Testosterone metabolism mini
- Template:Tissue-specific estrogenic and antiestrogenic activity of SERMs
- Template:Transdermal estradiol patches marketed in the United States